What are the treatment options for an adult patient with Dupuytren's contracture in the hands?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Dupuytren's Contracture in the Hands

For Dupuytren's contracture, collagenase clostridium histolyticum injection is the preferred first-line treatment for isolated metacarpophalangeal (MCP) joint contractures, while limited fasciectomy remains the gold standard for extensive disease involving both MCP and proximal interphalangeal (PIP) joints, offering the longest disease-free interval despite longer recovery. 1, 2, 3

Treatment Algorithm Based on Disease Severity

Mild to Moderate Contracture (MCP Joint Only)

Collagenase injection (Xiaflex 0.58 mg) should be your first choice, as it achieves 44.4% complete correction to 0-5° of normal extension and provides a mean 70.5% reduction in contracture degree with minimal downtime 3. This treatment:

  • Requires up to 3 injections per cord, with cord disruption attempted 24 hours after injection using standardized finger extension 3
  • Produces mean range of motion improvement of 35.4° 3
  • Results in no tendon ruptures or systemic allergic reactions in clinical trials 3
  • Achieves 50.7% success rate across all joint types in open-label extension studies 3

Needle aponeurotomy is an alternative minimally invasive option, particularly when combined with ultrasound guidance and local anesthetic injection, though evidence is limited to case reports showing dramatic symptom relief 4. This approach offers immediate results with minimal recovery time 1.

Extensive Disease (MCP + PIP Involvement)

Limited fasciectomy is the definitive treatment for contractures involving multiple joints, as 87.1% of hand surgeons recognize it provides the longest disease-free interval 2. This surgical approach:

  • Requires lengthy postoperative rehabilitation but delivers durable results 1
  • Is preferred by plastic surgeons over collagenase for young, working patients (plastic surgeons favor fasciectomy while orthopedic surgeons prefer collagenase in this scenario) 2
  • Should be performed by experienced hand surgeons given the complexity and complication risk 5

Recurrent or Severe Contracture

Proceed directly to open fasciectomy rather than repeating minimally invasive procedures, as patients with severe or recurrent disease have higher complication rates regardless of treatment modality 5. Consider primary amputation only for uncorrectable contractures with significant necrosis, paresis, ischemic pain, or sepsis 6.

Critical Treatment Considerations

Patient Selection Factors

  • Age and activity level matter: For young, working patients amenable to any option, 42.7% of surgeons use collagenase, though plastic and general surgeons lean toward fasciectomy 2
  • Patient goals must drive decisions: Balance functional requirements, recovery time tolerance, and complication acceptance 5
  • Contracture location is decisive: MCP-only disease favors collagenase; combined MCP-PIP disease favors fasciectomy 2

Complications to Anticipate

The most serious complications include 5:

  • Digital nerve injury or postoperative neurapraxia
  • Flexor tendon injury or rupture (one flexion pulley rupture reported with collagenase) 3
  • Delayed wound healing or skin necrosis (primarily with surgical approaches)
  • Contracture recurrence (no recurrence observed at 90 days post-collagenase in trials) 3
  • Hematoma and infection (surgical complications)

Common Pitfalls to Avoid

Do not use collagenase for PIP joint contractures as primary treatment when combined with MCP involvement—the success rate drops and fasciectomy provides superior long-term outcomes 2, 3.

Do not promise permanent correction with any modality—recurrence is inherent to Dupuytren's disease progression, though fasciectomy offers the longest disease-free interval 2, 5.

Patient education is paramount before any intervention—explicitly discuss that all treatments carry recurrence risk, and complications increase with disease severity 5.

Adjunctive Conservative Measures

While awaiting definitive treatment or for early disease, implement 7:

  • Daily static stretching exercises when pain is minimal, holding terminal stretch for 10-30 seconds 7
  • Superficial moist heat before exercises to improve effectiveness 7
  • Appropriate orthotics to counteract deforming forces, though avoid prolonged use beyond necessary healing periods 7

Avoid benzodiazepines entirely during any recovery period, as they impair neurological recovery and cause excessive sedation 8, 7.

References

Guideline

Surgical Management of Flexion Contracture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Muscle Contractures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Spastic Paraparesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the best treatment approach for a patient with Dupuytren's contracture and a ganglion cyst in the palm?
What are the assessment and treatment options for Dupuytren's contracture?
What are the treatment options for Dupuytren's (Dupuytren's contracture) contracture?
What are the treatment options for Dupuytren's Contracture?
What are the treatment guidelines for Dupuytren contractures?
If I'm an adult patient with a history of gastrointestinal issues, currently undergoing treatment for Small Intestine Bacterial Overgrowth (SIBO) and suspected histamine intolerance, and I've taken 20mg of Famotidine (Famotidine) in the morning but still experience symptoms, can I take an additional 20mg of Famotidine (Famotidine) in the evening as prescribed by my primary healthcare provider?
What lab tests should be ordered for a patient with a history of recurrent Acute Kidney Injury (AKI) and hyperkalemia, currently with impaired renal function and a stage 4 sacral ulcer, who is taking an Angiotensin-Converting Enzyme (ACE) inhibitor or Angiotensin Receptor Blocker (ARB), Lokelma (sodium zirconium cyclosilicate), and has recently experienced vaginal bleeding treated with megestrol acetate?
What is the significance and management of a subclinical microinfarction on a head MRI in an older adult with a history of vascular risk factors?
Can a patient with a urinary tract infection and possible anaerobic bacterial or protozoal infection take Macrobid (nitrofurantoin) and Flagyl (metronidazole) together?
What are the risks and benefits of using Jardiance (empagliflozin) or Farxiga (dapagliflozin) in patients with type 2 diabetes?
What is the management approach for a patient with Branchial Oto Renal (BOR) syndrome, a rare genetic disorder characterized by congenital branchial cleft anomalies, hearing loss, and impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.